Abstract: A vehicle part with at least one integrated photovoltaic element includes a part body, at least one area of a barrier layer disposed on at least a portion of the surface of the part body; and at least one photovoltaic element disposed over an area of the barrier layer. Paint covers the portions of the surface of the part body surrounding the photovoltaic elements. A method of making a vehicle part having at least one integrated photovoltaic element includes applying at least one area of a barrier layer on at least a portion of the surface of the part and applying at least one photovoltaic element over an area of the barrier layer. A protective layer is applied over the surface of the photovoltaic element, the surface of the part is painted, and the protective layer can then be removed to expose the photovoltaic element.

Abstract: Aspects of the disclosure include variable transmittance laminates having an embedded thermally conductive multi-layer for auto-shading applications. An exemplary vehicle includes a lighting system having a light source and a housing for the light source. A variable transmittance laminate is positioned such that light emitted from the housing passes through the variable transmittance laminate. The variable transmittance laminate includes a thermally conductive multi-layer and an auto-shading film on the thermally conductive multi-layer. The auto-shading film includes discrete substructures which vary in alignment in response to an electric field. A wire is embedded in the auto-shading film and a controller is electrically coupled to the wire. The controller switchably causes the wire to deliver the electric field to the discrete substructures. The variable transmittance laminate has a first transmittance when a switch is in a first state and a second transmittance when the switch in in a second state.

Abstract: Some embodiments disclosed herein are directed to controlling tinting levels of dimmable glass on vehicles. Other embodiments may be disclosed or claimed.

Abstract: The present disclosure provides a liquid suck-back system and a liquid suck-back method, and belongs to the technical field of suck-back of liquid. The liquid suck-back system includes a suck-back pipeline and a suck-back pump. The suck-back pipeline includes a first port and a second port, the first port is connected to the suck-back pump, and the second port is connected to a liquid supply pipeline. The suck-back pipeline includes a suck-back valve and a water return bay, the liquid supply pipeline is configured to supply liquid chemicals, and the suck-back pump is configured to suck back residual liquid chemicals in the liquid supply pipeline when the liquid supply pipeline stops supplying liquid chemicals.

Abstract: A microLED lighting module is disclosed. The microLED lighting module includes a micromodule having one or more transparent polymer layers thereon. Additionally, the one or more transparent polymer lavers are configured to maintain a temperature of the microLED lighting module below approximately 220° C.

Abstract: A body component for a transportation vehicle comprising an e-paper visible from a front side of the body component; a thermally protective material at least partially surrounding the e-paper; an injection molded body element located around at least a portion of the thermally protective film can be used on a transportation device to provide a digital image.

Abstract: The present disclosure relates to a gene recombinant vector of a collagenase, comprising a collagenase gene, wherein an amino acid sequence of a collagenase encoded by the collagenase gene is shown in SEQ ID NO. 1; moreover, a genetically engineered strain of the collagenase and a preparation method of the collagenase are also disclosed; and the collagenase prepared according to the invention is capable of degrading a bone collagen, and improving a yield of a low-molecular-weight bone collagen peptide.

Abstract: The present invention relates to the field of genetic engineering, particularly to a glucoamylase TIGa15, gene and application thereof. Said glucoamylase comprises the amino acid sequence of SEQ ID NO:1 or SEQ ID NO:2 and has the excellent enzymic properties, which can be applied to feed, food, and medicine industries, can be industrially produce with the genetic engineering technics.

Abstract: The present disclosure relates to a gene recombinant vector of a collagenase, comprising a collagenase gene, wherein an amino acid sequence of a collagenase encoded by the collagenase gene is shown in SEQ ID NO. 1; moreover, a genetically engineered strain of the collagenase and a preparation method of the collagenase are also disclosed; and the collagenase prepared according to the invention is capable of degrading a bone collagen, and improving a yield of a low-molecular-weight bone collagen peptide.

Abstract: The present disclosure provides a liquid suck-back system and a liquid suck-back method, and belongs to the technical field of suck-back of liquid. The liquid suck-back system includes a suck-back pipeline and a suck-back pump. The suck-back pipeline includes a first port and a second port, the first port is connected to the suck-back pump, and the second port is connected to a liquid supply pipeline. The suck-back pipeline includes a suck-back valve and a water return bay, the liquid supply pipeline is configured to supply liquid chemicals, and the suck-back pump is configured to suck back residual liquid chemicals in the liquid supply pipeline when the liquid supply pipeline stops supplying liquid chemicals.

Abstract: The disclosure discloses a biomarker in osteoporosis intervention therapy by bone peptide, the biomarker including a lipid and lipid-like molecule, an organic acid and its derivative, and/or a neurotransmitter, wherein the lipid and lipid-like molecule includes one or more of taurine, arachidonic acid, 1-palmitoyl-2-hydroxy-sn-glycerol-3-phosphoethanolamine, (4Z, 7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-docosahexaenoic acid, 1-stearoyl-2-hydroxy-sn-glycerol-3-phosphocholine, taurodeoxycholic acid, taurochenodeoxycholate or taurocholic acid. The disclosure discloses a screening method of a biomarker in the anti-osteoporosis activity of bone peptide. The disclosure discloses a use of the biomarker.

Abstract: The present invention relates to the field of genetic engineering, particularly to a glucoamylase TIGal5, gene and application thereof. Said glucoamylase comprises the amino acid sequence of SEQ ID NO:1 or SEQ ID NO:2 and has the excellent enzymic properties, which can be applied to feed, food, and medicine industries, can be industrially produce with the genetic engineering technics.

Abstract: Methods and compositions for preventing and/or treating viral infections are provided. The methods involve administering an agent that stabilizes or enhances Axin1 activity, e.g. and agent that inhibits tankyrase. Administration of the agent stimulates or increases interferon activity, thereby preventing or lessening at least one symptom of virus infection. The virus infection may be caused by a respiratory virus such as influenza vims.

Abstract: Methods and compositions for preventing and/or treating viral infections are provided. The methods involve administering an agent that stabilizes or enhances Axin1 activity, e.g. and agent that inhibits tankyrase. Administration of the agent stimulates or increases interferon activity, thereby preventing or lessening at least one symptom of virus infection. The virus infection may be caused by a respiratory virus such as influenza vims.